Sanofi (SNYNF) stock
SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY
$78.48−0.07 (-0.09%)
Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –
Sanofi net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was €7.81B, up 40.5% from the year before. Over ten years it grew 6.2% a year on average. The highest annual figure on record is €12.29B in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €7.81B | +40.5% |
| FY2024 | Dec 31, 2024 | €5.56B | +3.0% |
| FY2023 | Dec 31, 2023 | €5.40B | -35.5% |
| FY2022 | Dec 31, 2022 | €8.37B | +34.5% |
| FY2021 | Dec 31, 2021 | €6.22B | -49.4% |
| FY2020 | Dec 31, 2020 | €12.29B | +346.4% |
| FY2019 | Dec 31, 2019 | €2.75B | -36.0% |
| FY2018 | Dec 31, 2018 | €4.31B | -48.8% |
| FY2017 | Dec 31, 2017 | €8.42B | +78.7% |
| FY2016 | Dec 31, 2016 | €4.71B | +9.8% |
| FY2015 | Dec 31, 2015 | €4.29B | – |
See a number that looks wrong?